SC 13G Filing

Company

Aclaris Therapeutics, Inc.

Filed

November 25, 2024

Accession Number

0000929638-24-004037

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →